Sciele Pharma to Present at the Piper Jaffray Health Care Conference
Posted on: Monday, 20 November 2006, 12:00 CST
Sciele Pharma, Inc. (NASDAQ:SCRX), a specialty pharmaceutical company, today announced that Darrell Borne, Chief Financial Officer, will make a presentation at the Piper Jaffray Health Care Conference at the Pierre Hotel in New York City on Thursday, November 30, 2006, at 1:00 p.m. Eastern Time.
The audio presentation is being broadcast on the Internet and may be accessed at the Company's website, www.sciele.com.
Sciele Pharma, Inc. Background
Sciele Pharma, Inc. is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular/Metabolic and Women's Health. The Company's Cardiovascular/Metabolic products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and Type 2 diabetes, and its Women's Health products are designed to improve the health and well-being of mothers and their babies. Headquartered in Atlanta, Georgia, and founded in 1992, Sciele Pharma employs more than 700 people. The Company's success is based on placing the needs of patients first, improving health and quality of life and implementing its business platform -- an Entrepreneurial Spirit, Innovation, Speed of Execution, Simplicity and Teamwork. For more information about Sciele Pharma and its products, visit www.sciele.com.
Source: Business Wire
Related Articles
- Sciele Pharma and Plethora Solutions Announce Positive Phase III Clinical Results of PSD502 for Premature Ejaculation
- Sciele Pharma to Present at Bank of America Health Care Conference
- Sciele Pharma to Webcast Product Development Pipeline Presentation
- Sciele Pharma to Present at the 19th Annual Piper Jaffray Health Care Conference
- Sciele Pharma Announces FDA Acceptance of NDA for Summers Laboratories' Head Lice Treatment
- Sciele Pharma Acquires a Novel, Patented Treatment for Head Lice From Summers Laboratories, Inc.
- Sciele Pharma Introduces OSTIVA(TM), a New Women's Health Product
- First Horizon Pharmaceutical Corporation Stockholders Approve Name Change to Sciele Pharma, Inc.
- Health Products Research Reports Pediatricians Are 2nd Largest Target Audience for Pharma Companies
User Comments (0)

RSS Feeds